While constitutive STAT3 activity had initially been attributed to deregulated growth factor signaling, recent studies have identified STAT3 as an important mediator of carcinogenesis driven by chronic inflammation, obesity and/or metabolism, cancer stem cells (CSCs) [9–15]. The gene discussed is STAT3; the disease is cancer.